» Articles » PMID: 28425925

Evaluation of the Immunomodulatory Properties of Streptococcus Suis and Group B Streptococcus Capsular Polysaccharides on the Humoral Response

Overview
Journal Pathogens
Date 2017 Apr 21
PMID 28425925
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

and group B (GBS) are encapsulated streptococci causing septicemia and meningitis. Antibodies (Abs) against capsular polysaccharides (CPSs) have a crucial protective role, but the structure/composition of the CPS, including the presence of sialic acid, may interfere with the generation of anti-CPS Ab responses. We investigated the features of the CPS-specific Ab response directed against serotypes 2 and 14 and GBS serotypes III and V after infection or immunization with purified native or desialylated CPSs in mice. Whereas -infected mice developed a very low/undetectable CPS-specific IgM response, significant anti-CPS IgM titers were measured in GBS-infected animals (especially for type III GBS). No isotype switching was detected in - or GBS-infected mice. While the expression of sialic acid was essential for the immunogenicity of purified GBS type III CPS, this sugar was not responsible for the inability of purified types 2, 14 and GBS type V CPSs to induce a specific Ab response. Thus, other biochemical criteria unrelated to the presence of sialic acid may be responsible for the inaptitude of the host immune system to mount an effective response against certain and GBS CPS types.

Citing Articles

Unmutated but T cell dependent IgM antibodies targeting Streptococcus suis play an essential role in bacterial clearance.

Dolbec D, Lehoux M, de Beauville A, Zahn A, Di Noia J, Segura M PLoS Pathog. 2024; 20(1):e1011957.

PMID: 38241393 PMC: 10829992. DOI: 10.1371/journal.ppat.1011957.


surface-antigen recognition by antibodies and bacterial elimination is influenced by capsular polysaccharide structure.

Dolbec D, Lehoux M, Okura M, Takamatsu D, Gottschalk M, Segura M Front Cell Infect Microbiol. 2023; 13:1228496.

PMID: 37545852 PMC: 10401424. DOI: 10.3389/fcimb.2023.1228496.


Vaccine against Infection in Pig Based on Alternative Carrier Protein Conjugate.

Kralova N, Stepanova H, Gebauer J, Norek A, Matiaskova K, Zouharova M Vaccines (Basel). 2022; 10(10).

PMID: 36298485 PMC: 9612095. DOI: 10.3390/vaccines10101620.


Comparative Molecular Modelling of Capsular Polysaccharide Conformations in Serotypes 1, 2, 1/2 and 14 Identifies Common Epitopes for Antibody Binding.

Kuttel M Front Mol Biosci. 2022; 9:830854.

PMID: 35211512 PMC: 8861514. DOI: 10.3389/fmolb.2022.830854.


Discovery of Oligosaccharide Antigens for Semi-Synthetic Glycoconjugate Vaccine Leads against Streptococcus suis Serotypes 2, 3, 9 and 14*.

Zhang S, Sella M, Sianturi J, Priegue P, Shen D, Seeberger P Angew Chem Int Ed Engl. 2021; 60(26):14679-14692.

PMID: 33852172 PMC: 8252040. DOI: 10.1002/anie.202103990.


References
1.
Lemire P, Houde M, Lecours M, Fittipaldi N, Segura M . Role of capsular polysaccharide in Group B Streptococccus interactions with dendritic cells. Microbes Infect. 2012; 14(12):1064-76. DOI: 10.1016/j.micinf.2012.05.015. View

2.
Jennings H, Roy R, Gamian A . Induction of meningococcal group B polysaccharide-specific IgG antibodies in mice by using an N-propionylated B polysaccharide-tetanus toxoid conjugate vaccine. J Immunol. 1986; 137(5):1708-13. View

3.
Le Doare K, Heath P . An overview of global GBS epidemiology. Vaccine. 2013; 31 Suppl 4:D7-12. DOI: 10.1016/j.vaccine.2013.01.009. View

4.
Cariappa A, Takematsu H, Liu H, Diaz S, Haider K, Boboila C . B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase. J Exp Med. 2008; 206(1):125-38. PMC: 2626685. DOI: 10.1084/jem.20081399. View

5.
Taillardet M, Haffar G, Mondiere P, Asensio M, Gheit H, Burdin N . The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells. Blood. 2009; 114(20):4432-40. DOI: 10.1182/blood-2009-01-200014. View